- Home
- MDGL vs BPOP Comparison
MDGL vs BPOP Comparison
Compare MDGL & BPOP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MDGL
- BPOP
- Stock Information
- Founded
- MDGL 2011
- BPOP 1893
- Country
- MDGL United States
- BPOP United States
- Employees
- MDGL N/A
- BPOP N/A
- Industry
- MDGL Biotechnology: Pharmaceutical Preparations
- BPOP Major Banks
- Sector
- MDGL Health Care
- BPOP Finance
- Exchange
- MDGL Nasdaq
- BPOP Nasdaq
- Market Cap
- MDGL 7.1B
- BPOP 7.1B
- IPO Year
- MDGL N/A
- BPOP N/A
- Fundamental
- Price
- MDGL $336.23
- BPOP $100.69
- Analyst Decision
- MDGL Buy
- BPOP Buy
- Analyst Count
- MDGL 14
- BPOP 8
- Target Price
- MDGL $351.67
- BPOP $110.00
- AVG Volume (30 Days)
- MDGL 357.1K
- BPOP 473.3K
- Earning Date
- MDGL 02-26-2025
- BPOP 01-28-2025
- Dividend Yield
- MDGL N/A
- BPOP 2.78%
- EPS Growth
- MDGL N/A
- BPOP 13.83
- EPS
- MDGL N/A
- BPOP 8.56
- Revenue
- MDGL $76,813,000.00
- BPOP $2,684,255,000.00
- Revenue This Year
- MDGL N/A
- BPOP N/A
- Revenue Next Year
- MDGL $195.95
- BPOP $6.89
- P/E Ratio
- MDGL N/A
- BPOP $11.76
- Revenue Growth
- MDGL N/A
- BPOP 4.30
- 52 Week Low
- MDGL $189.00
- BPOP $80.60
- 52 Week High
- MDGL $368.29
- BPOP $106.81
- Technical
- Relative Strength Index (RSI)
- MDGL 52.41
- BPOP 47.18
- Support Level
- MDGL $334.13
- BPOP $101.21
- Resistance Level
- MDGL $354.49
- BPOP $106.81
- Average True Range (ATR)
- MDGL 13.20
- BPOP 2.36
- MACD
- MDGL 0.16
- BPOP -0.27
- Stochastic Oscillator
- MDGL 43.12
- BPOP 14.17
About MDGL Madrigal Pharmaceuticals Inc.
Madrigal Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular-metabolic diseases and non-alcoholic steatohepatitis (NASH). The product portfolio of the company includes MGL-3196, an orally administered, small-molecule liver-directed B-selective THR agonist, which is used for the treatment of non-alcoholic steatohepatitis and familial hypercholesterolemia. Also, MGL-3196 reduces triglycerides in the plasma and liver by increasing fat metabolism and shows an anti-diabetic action.
About BPOP Popular Inc.
Popular Inc, based in Puerto Rico, is a financial holding company with four main subsidiaries: Banco Popular de Puerto Rico, a bank in Puerto Rico in terms of assets; Banco Popular North America, its banking operation in the continental United States; Evertec, a data processor; and Popular Financial Holdings, a diversified financial services company. The Corporation's reportable segments consist of Banco Popular de Puerto Rico and Popular U.S.